CTRI/2018/10/015943已完成未知
COMPARATIVE STUDY TO ASSESS THE EFFICACY AND COSTEFFICIENCY OF IMMUNOLOGICALLY- TARGETED LOW DOSERITUXIMAB PROTOCOL WITH THE CONVENTIONALRHEUMATOID ARTHRITIS PROTOCOL IN SIGNIFICANT PEMPHIGUS
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •PATIENTS OF PEMPHIGUS VULGARIS OR PEMPHIGUS FOLIACEOUS IN THE ABOVE MENTIONED AGE GROUP WITH SIGNIFICANT CLINICAL DISEASE WITH PDAI( PEMPHIGUS DISEASE ACTIVITY INDEX) SCORE >15 AND WHO ARE WILLING FOR MONTHLY FOLLOW UP VISITS FOR 12 MONTHS.
排除标准
- •PATIENTS WITH ACTIVE OR LATENT INFECTIONS LIKE HEPATITIS, TB OR SEPSIS.PREGNANT AND LACTATING FEMALES, PATIENTS WITH KNOWN CARDIAC ABNORMALITIES OR ARRHYTHMIA, SEVERELY DECREASED BONE MARROW FUNCTIONS, KNOWN HYPERSENSITIVITY TO MURINE PROTEINS OR ORAL CORTICOSTEROIDS. PATIENTS WHO HAVE RECEIVED RITUXIMAB IN PRECEDING 12 MONTHS OR DEXAMETHASONE PULSE THERAPY IN PRECEDING 3 MONTHS WILL ALSO BE EXCLUDED.
研究者
相似试验
招募中
不适用
Comparison of the cost and effectiveness analysis of combined exercises on insulin consumption and some related factors on type 2 diabetic patientstype 2 diabetes.Type 2 diabetes mellitusICD-10-E11IRCT20180530039909N1ational Health Insurance Research Center68
已完成
不适用
A study to compare the costs between intravenous Magnesium Sulfate and placebo in acute exacerbations of chronic obstructive pulmonary diseaseCTRI/2018/04/013309Kempegowda institute of medical sciences60
已完成
不适用
Assessing the Effectiveness and Cost-effectiveness of Audit and Feedback on physician's prescribing indicatorsdrug use indicators.Problem related to care-provider dependency, unspecifiedIRCT201106086740N1Vice chanselor for Research of Tehran University of Medical Sciences and Health Services800
尚未招募
4 期
Comparison of clindamycin - benzoyl peroxide versus adapalene - benzoyl peroxide in patients of acneCTRI/2019/04/018786Government medical college Nagpur
尚未招募
不适用
â??Comparing topical Clindamycin - Adapalene with oral doxycycline 100mg versus topical Benzoyl peroxide - Adapalene with oral doxycycline 100mg in moderate to severe facial acne vulgarisCTRI/2023/02/050053tamil selvi